These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 34940799)
1. Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors: A Review. Sadagopan A; Michelakos T; Boyiadzis G; Ferrone C; Ferrone S JAMA Oncol; 2022 Mar; 8(3):462-473. PubMed ID: 34940799 [TBL] [Abstract][Full Text] [Related]
2. HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy. Maggs L; Sadagopan A; Moghaddam AS; Ferrone S Trends Cancer; 2021 Dec; 7(12):1089-1101. PubMed ID: 34489208 [TBL] [Abstract][Full Text] [Related]
3. Defective HLA class I antigen processing machinery in cancer. Cai L; Michelakos T; Yamada T; Fan S; Wang X; Schwab JH; Ferrone CR; Ferrone S Cancer Immunol Immunother; 2018 Jun; 67(6):999-1009. PubMed ID: 29487978 [TBL] [Abstract][Full Text] [Related]
4. HLA Class I Antigen Processing Machinery Defects in Cancer Cells-Frequency, Functional Significance, and Clinical Relevance with Special Emphasis on Their Role in T Cell-Based Immunotherapy of Malignant Disease. Seliger B; Ferrone S Methods Mol Biol; 2020; 2055():325-350. PubMed ID: 31502159 [TBL] [Abstract][Full Text] [Related]
6. Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells. Concha-Benavente F; Srivastava R; Ferrone S; Ferris RL Oral Oncol; 2016 Jul; 58():52-8. PubMed ID: 27264839 [TBL] [Abstract][Full Text] [Related]
7. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma. Raffaghello L; Nozza P; Morandi F; Camoriano M; Wang X; Garrè ML; Cama A; Basso G; Ferrone S; Gambini C; Pistoia V Cancer Res; 2007 Jun; 67(11):5471-8. PubMed ID: 17545629 [TBL] [Abstract][Full Text] [Related]
8. Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells. Sabbatino F; Schwab JH; Ferrone S; Ferrone CR Clin Transpl; 2013; ():453-63. PubMed ID: 25095541 [TBL] [Abstract][Full Text] [Related]
9. SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells. Leibowitz MS; Srivastava RM; Andrade Filho PA; Egloff AM; Wang L; Seethala RR; Ferrone S; Ferris RL Clin Cancer Res; 2013 Feb; 19(4):798-808. PubMed ID: 23363816 [TBL] [Abstract][Full Text] [Related]
10. STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients. Srivastava RM; Trivedi S; Concha-Benavente F; Hyun-Bae J; Wang L; Seethala RR; Branstetter BF; Ferrone S; Ferris RL Cancer Immunol Res; 2015 Aug; 3(8):936-45. PubMed ID: 25972070 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens. Morandi F; Raffaghello L; Bianchi G; Meloni F; Salis A; Millo E; Ferrone S; Barnaba V; Pistoia V Stem Cells; 2008 May; 26(5):1275-87. PubMed ID: 18292209 [TBL] [Abstract][Full Text] [Related]
12. Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer. Gettinger S; Choi J; Hastings K; Truini A; Datar I; Sowell R; Wurtz A; Dong W; Cai G; Melnick MA; Du VY; Schlessinger J; Goldberg SB; Chiang A; Sanmamed MF; Melero I; Agorreta J; Montuenga LM; Lifton R; Ferrone S; Kavathas P; Rimm DL; Kaech SM; Schalper K; Herbst RS; Politi K Cancer Discov; 2017 Dec; 7(12):1420-1435. PubMed ID: 29025772 [TBL] [Abstract][Full Text] [Related]
13. Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors. Patel SS; Nota SP; Sabbatino F; Nielsen GP; Deshpande V; Wang X; Ferrone S; Schwab JH Clin Orthop Relat Res; 2021 Jun; 479(6):1373-1382. PubMed ID: 33273248 [TBL] [Abstract][Full Text] [Related]
14. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer. Ayshamgul H; Ma H; Ilyar S; Zhang LW; Abulizi A Chin Med J (Engl); 2011 Feb; 124(3):341-6. PubMed ID: 21362330 [TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors. Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289 [TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance. Ferris RL; Hunt JL; Ferrone S Immunol Res; 2005; 33(2):113-33. PubMed ID: 16234579 [TBL] [Abstract][Full Text] [Related]
17. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer. Seliger B; Stoehr R; Handke D; Mueller A; Ferrone S; Wullich B; Tannapfel A; Hofstaedter F; Hartmann A Cancer Immunol Immunother; 2010 Apr; 59(4):529-40. PubMed ID: 19820934 [TBL] [Abstract][Full Text] [Related]
18. Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy. Han J; Dong Y; Zhu X; Reuben A; Zhang J; Xu J; Bai H; Duan J; Wan R; Zhao J; Bai J; Xia X; Yi X; Cheng C; Wang J; Wang Z Nat Commun; 2024 Feb; 15(1):1199. PubMed ID: 38331912 [TBL] [Abstract][Full Text] [Related]
19. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma. Han LY; Fletcher MS; Urbauer DL; Mueller P; Landen CN; Kamat AA; Lin YG; Merritt WM; Spannuth WA; Deavers MT; De Geest K; Gershenson DM; Lutgendorf SK; Ferrone S; Sood AK Clin Cancer Res; 2008 Jun; 14(11):3372-9. PubMed ID: 18519766 [TBL] [Abstract][Full Text] [Related]